David G. Orloff, MD
Executive Director, Medpace Regulatory Affairs
Dr. Orloff is an endocrinologist and has 11 years of regulatory experience, with major foci in diabetes,
obesity, and lipid metabolism. He is the immediate past director of the Division of Metabolism and
Endocrinology Products within the Center for Drug Evaluation and Research (CDER) of the FDA.
5375 Medpace Way
Cincinnati, Ohio 45227